Parinita Swarnkar

8PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersSite-based writing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Challenging the Treatment Threshold: Early Faricimab Prevents Vision Loss in nAMD - A Real-World Welsh Experience.

|Apr 01, 2026
Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study.

Christopher Stewart, Jaskaran Singh Bhangu, Parinita Keshav Swarnkar

|Sep 09, 2022
De-escalation of breast cancer treatment for Her2-positive breast cancer.

Parinita Swarnkar, Lara Mokbel, Kefah Mokbel

|May 03, 2022
Axillary radiation alone is a suboptimal treatment for ypN + in patients with triple negative breast cancer and axillary lymph node dissection should be considered in this setting.

Parinita Keshav Swarnkar, Kefah Mokbel

|May 05, 2021
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach.

Parinita K Swarnkar, Kefah Mokbel

|Apr 30, 2021
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.

Parinita K Swarnkar, Kefah Mokbel

Pageof 2

Frequent Collaborators

2 joint publications

Christopher Stewart

2 joint publications

Mahmoud Husseiny Awad

1 joint publications

Jaskaran Singh Bhangu

1 joint publications

Mohammed Rifat